Phenoxybenzamine drug data and news

Phenoxybenzamine drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Phenoxybenzamine
Brand Names/Synonyms 688A; A 688; B019; Bensylyt; Bensylyt Nen; Bensylyte; Benzylyt; Blocadren; CCRIS 505; CHEMBANK1395; Dibenylin; Dibenyline; Dibenzylene; Dibenzyline; Dibenzyline Hydrochloride; Dibenzyran; Fenossibenzamina [Dcit]; Fenoxibenzamina [Inn-Spanish]; HSDB 4005; Phenoxybenzamine; Phenoxybenzamine Hcl; Phenoxybenzamine Hydrochloride; Phenoxybenzaminum [Inn-Latin]; Phenyoxybenzaminehydrochloride; Pob Hcl
Indication Phaeochromocytoma (malignant);Benign prostatic hypertrophy;Malignant essential hypertension
Sponsored links
Description Not Available
Pharmacology Phenoxybenzamine is indicated for the control of episodes of hypertension and sweating that occur with a disease called pheochromocytoma. If tachycardia is excessive, it may be necessary to use a beta-blocking agent concomitantly. Phenoxybenzamine is a long-acting, adrenergic, alpha-receptor blocking agent which can produce and maintain "chemical sympathectomy" by oral administration. It increases blood flow to the skin, mucosa and abdominal viscera, and lowers both supine and erect blood pressures. It has no effect on the parasympathetic system. Phenoxybenzamine works by blocking alpha receptors in certain parts of the body. Alpha receptors are present in the muscle that lines the walls of blood vessels. When the receptors are blocked by Phenoxybenzamine, the muscle relaxes and the blood vessels widen. This widening of the blood vessels results in a lowering of blood pressure.
Mechanism Of Action Phenoxybenzamine produces its therapeutic actions by blocking alpha receptors, leading to a muscle relaxation and a widening of the blood vessels. This widening of the blood vessels results in a lowering of blood pressure.
Phenoxybenzamine News
(When available)
[an error occurred while processing this directive]
Dosage Forms Not Available
Drug_Category Vasodilator Agents; Antihypertensive Agents; ATC:C04AX02
Absorption Not Available
Interactions Interactions for Phenoxybenzamine:

Dibenzyline (phenoxybenzamine hydrochloride) may interact with compounds that stimulate both alpha- and beta- adrenergic receptors (i.e., epinephrine) to produce an exaggerated hypotensive response and tachycardia.

Dibenzyline blocks hyperthermia production by levarterenol, and blocks hypothermia production by reserpine.

Toxicity Not Available
Organisms Affected Humans and other mammals
Chemical IUPAC Name N-benzyl-N-(2-chloroethyl)-1-phenoxy-propan-2-amine
Chemical Formula C18H22ClNO
Molecular Weight 303.826 g/mol
Smiles String CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2
Melting Point 39 °C
Water Solubility Not Available
State Solid
LogP/Hphobicity 4.601
Isoelectric Point Not Available
Biotransformation Not Available
Half Life 24 hours
Protein Binding [%] Not Available
RxList Link RXlist
Sponsored links
Drug Reference http://www.drugs.com/cons/Phenoxybenzamine.html
http://www.rxlist.com/cgi/generic3/phenoxybenz.htm
Drug Type Approved Drug
Accession No APRD00651
CAS Registry Number 59-96-1
KEGG Compound ID C07435
PubChem ID SID:9639
PharmGKB ID PA450919
SwissProt ID Not Available
GenBank ID Not Available
Drug ID Number [DIN] Not Available

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org